Innovations in Clinical Neuroscience

04/20/2026

As our brand continues to evolve we have decided to start fresh and create a new page. In one week this page will no longer be active and we will be sharing all updates and posts from our new page. Follow today to stay up to date with the latest advancements in clinical neuroscience! Follow here: https://www.facebook.com/profile.php?id=61568857645823

04/06/2026

Hear from Dr. Jason Aldred, MD, as he discusses Vyalev (foscarbidopa/foslevodopa), highlighting possible side effects when treating patients with Parkinson's disease. Learn more: https://ow.ly/45kW50YEBPI

Peer-reviewed evidence-based information in neuroscience research and practice, including psychiatry, neurology, psychology

03/31/2026

This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by PRMS (https://ow.ly/3eHr50YsQxe), a manager of medical professional liability insurance programs with services that include risk management consultation and other resources offered to health care providers to help improve patient outcomes and reduce professional liability risk. Learn more: https://ow.ly/5BBf50YsQxg

03/30/2026

Early detection and outcome prediction of stroke are crucial for enhancing poststroke care. We explored the diagnostic and prognostic potential of bioactive adrenomedullin (bio-ADM) in stroke through a systematic review and meta-analysis. Learn more: https://ow.ly/gM0850YsQco

03/26/2026

Recent decades have seen a surge in empirical support for the clinical application of noninvasive neuromodulation technology, such as repetitive transcranial magnetic stimulation (rTMS). The aim of this perspective is to review the emerging research exploring the literature on combined psychotherapy with rTMS. Learn more: https://ow.ly/V2Oo50YsPO8

03/24/2026

This research describes the development of a probiotic-infused carbamazepine dosage form. This dosage form combines carbamazepine with probiotics, proposing the potential use of both active pharmaceutical ingredients in a single dosage form. Learn more: https://ow.ly/FKEO50YsPfz

03/19/2026

Multiple endocrine neoplasia 2A (MEN2A) is an uncommon autosomal dominant disorder characterized by medullary thyroid cancer (MTC), parathyroid adenoma or hyperplasia, and pheochromocytoma with associated hypothyroidism, hyperparathyroidism, hypercalcemia, and catecholamine excess. Existing literature elucidates the correlation of depression with each endocrine condition. To our knowledge, this is the first case report emphasizing the multifaceted association of MEN2A and depression with contributory intergenerational psychosocial factors. Learn more: https://ow.ly/FiGX50YsNFh

03/17/2026

Chronic pain disorders of unknown etiology, including burning mouth syndrome, chronic pelvic pain, fibromyalgia, irritable bowel syndrome, myofascial pain syndrome, and temporomandibular joint disorders, have been demonstrated to result in a substantial reduction in quality of life. The neurobiological underpinnings of these conditions are characterized by a decline in the volume of white matter in the medial prefrontal cortex and alterations in the connectivity of the default mode network. Learn more: https://ow.ly/flOO50YsNwY

03/13/2026

Many psychiatric inpatients are prescribed complex medication regimens that include both psychiatric and medical drugs with high anticholinergic (ACH) activity. The cumulative ACH burden (ACB), arising from the pharmacodynamic additive effects of concomitant medication use, has been linked to a range of adverse effects. These include both short-term effects and long-term consequences. This study aims to determine the degree of ACB in a psychiatric inpatient hospital using current measurement assessment tools. Learn more: https://ow.ly/bn9O50YsNgC

03/12/2026

As internet and social media use become increasingly central to youth development, it is critical to address the unique opportunities and challenges these technologies pose for individuals with intellectual and developmental disabilities (IDD). This column explores how digital tools can enhance social connection, identity formation, adaptive skill-building, and access to therapeutic resources in youth with IDD, while also acknowledging the heightened risks of cyberbullying, overstimulation, exploitation, and digital exclusion. Learn more: https://ow.ly/khGq50YsoXN